Evidence map›Paper›PMID 34548862›Full record

ArticleInternational journal of health sciences

Treatment for chest pain intercurrence after breast cancer surgery using Godoy's intermittent skin therapy.

Jose Maria Pereira de Godoy, Henrique Jose Pereira de Godoy, Tania Dias Guimarães, Maria de Fatima Guerreiro Godoy

Abstract read
In one paragraph

Article in International journal of health sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jose Maria Pereira de GodoyDepartment of Cardiology and Cardiovascular Surgery, São José do Rio Preto School of Medicine (FAMERP), CNPq (National Council for Research and Development), Sao Jose do Rio Preto, Brazil.
Henrique Jose Pereira de GodoyPhysician, Medical Degree from Universidade Federal do Mato Grosso-Cuiabá-UFMT and Member Clínica Godoy Research Group, Sao Jose do Rio Preto, Brazil.
Tania Dias GuimarãesPhysiotherapist Member Clínica Godoy Research Group, São Jose do Rio Preto, Brazil.
Maria de Fatima Guerreiro GodoyOccupational Therapist, Professor in Graduate Program of São José do Rio Preto School of Medicine (FAMERP) and Member Clínica Godoy Research Group, Sao Jose do Rio Preto, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChest pain and swelling are routinely reported in women after breast cancer treatment and are often not valued by health professionals. In general, these patients suffer and without many effective solutions. The aim of the present study was to report the results of a novel technique for the treatment of chest pain related to breast cancer treatment.

methodsA clinical trial was conducted involving 25 women with chest pain resulting from the treatment of breast cancer and submitted to treatment for lymphedema at the Godoy School in 2018. Godoy's intermittent dermal therapy was performed on the participants 2-4 h/day for 2 days until the occurrence of a significant improvement or complete resolution of pain (measured using the visual analog pain scale).

resultsAll patients reported a significant reduction in pain in the first ½ h of treatment (

conclusionChronic chest pain in patients having been submitted to treatment for breast cancer can be significantly reduced with Godoy's intermittent skin therapy, achieving standards of normality or near normality within only a few sessions.

Indexed as

Breast cancerchest painGodoy’s intermittent skin therapytreatment

Identifiers

PMID34548862
PMCPMC8434843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.